U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc.

USRM - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$64.15K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.0-19%--0.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$64,151.00
Enterprise Value$9.01 Million
Earnings per Share$0
Beta0.67
Outstanding Shares591,558,288

Return

Return on Equity19.38%ROE
Return on Assets-4200.45%
Return on Invested Capital15.47%

Valuation & Multiples

P/E Ratio-0.02P/E Ratio
PEG0.18PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue109.8
Enterprise Value to EBIT-4.16
Enterprise Value to Net Income-4
Total Debt to Enterprise0.99
Debt to Equity-0.61Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About U.S. Stem Cell, Inc.

11 employees
CEO: Michael Tomas

U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of medical conditions, including both c...